NCT01497535 - Within-subject Variability of Insulin Detemir in Healthy Volunteers | Biotech Hunter

Enrollment

40

Participants

Timeline

Start Date

May 27, 2004

Primary Completion Date

October 31, 2004

Study Completion Date

October 31, 2004

Conditions

DiabetesHealthy

Interventions

DRUG

insulin detemir

On four different dosing days where subjects enter a 24-hour euglycaemic glucose clamp procedure, the subject will be allocated to one single dose of either 0.4 U/kg insulin detemir or 0.4 U/kg insulin glargine administered subcutaneously (s.c., under the skin)

DRUG

insulin glargine

On four different dosing days where subjects enter a 24-hour euglycaemic glucose clamp procedure, the subject will be allocated to one single dose of either 0.4 U/kg insulin detemir or 0.4 U/kg insulin glargine administered subcutaneously (s.c., under the skin)

Trial Locations (1)

41460

Novo Nordisk Investigational Site, Neuss